Jennifer Altomonte

II. Medizinische Klinik, Klinikum rechts der Isar der TU München

Affiliated withKlinikum rechts der Isar der TU München

Research Area

Biography

Jennifer Altomonte has not added Biography.
If you are Jennifer Altomonte and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2016

Other Publications

Article	Year
Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes\| PubMed ID: 11756332	2002
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes\| PubMed ID: 12086936	2002
Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes. Human gene therapy\| PubMed ID: 12228011	2002
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature\| PubMed ID: 12754525	2003
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. American journal of physiology. Endocrinology and metabolism\| PubMed ID: 12783775	2003
Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism: clinical and experimental\| PubMed ID: 12898458	2003
Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes\| PubMed ID: 15047611	2004
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. The Journal of clinical investigation\| PubMed ID: 15546000	2004
Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes\| PubMed ID: 15677494	2005
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. American journal of physiology. Endocrinology and metabolism\| PubMed ID: 16985262	2007
Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology\| PubMed ID: 16997836	2006
Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. Journal of lipid research\| PubMed ID: 17449907	2007
Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 18071337	2008
rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy. Human gene therapy\| PubMed ID: 18533893	2008
Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 18781139	2008
Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats. Hepatology (Baltimore, Md.)\| PubMed ID: 19003878	2008
Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. Archives of pharmacal research\| PubMed ID: 19280151	2009
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging\| PubMed ID: 19340488	2009
Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19809404	2010
Surgeon Yurii Voronoy (1895-1961) - a pioneer in the history of clinical transplantation: in memoriam at the 75th anniversary of the first human kidney transplantation. Transplant international : official journal of the European Society for Organ Transplantation\| PubMed ID: 19874569	2009
Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma. PloS one\| PubMed ID: 20539760	2010
Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization. Journal of hepatology\| PubMed ID: 21354233	2011
Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Investigative radiology\| PubMed ID: 21577121	2011
Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses. Microbial biotechnology\| PubMed ID: 21923638	2012
Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125. Journal of virology\| PubMed ID: 22345438	2012
Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 23939023	2013
Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma. Frontiers in oncology\| PubMed ID: 24795862	2014
PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 25609160	2015
Characterization of magnetic viral complexes for targeted delivery in oncology. Theranostics\| PubMed ID: 25897333	2015
Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25995341	2015